Meropenem-TF (Мeropenem)

Gold standard” of monotherapy of serious infections in inpatient settings. Active against a wide range of gram-positive (+) and gram-negative aerobic bacteria, majority of anaerobic bacteria. Used in therapy of serious polymicrobic infections of lower respiratory tract, urinary system infections, intraabdominal infections, gynecological infections, skin and soft tissue infections, bone and joint infections, endocarditis.

A highly potent carbapenem antibiotic drug. Active against gram-positive (+) and gram-negative (-) aerobic and anaerobic bacteria. Several times more active against Pseudomonas aeruginosa compared to meropenem and imipenem/cilastatin. Used in treatment of hospital-acquired (nosocomial) pneumonia, including ventilator-associated pneumonia; complicated intraabdominal infections; complicated infections of urinary system, including complicated and uncomplicated pyelonephritis, particularly pyelonephritis with accompanying bacteremia.

An effective bactericidal antibiotic for the treatment of infections caused by gram-negative and gram-positive bacteria. It has a bactericidal effect on proliferating pathogenic microorganisms, preventing the enzymatic synthesis of the bacterial cell wall.

Antituberculous polypeptide antibiotic with low toxicity and and good tolerance. It is used for the treatment of drug-resistant forms of pulmonary tuberculosis.